Quick Access

MAP3K7 Knockout HAP1 Cell Line

MAP3K7 Knockout HAP1 Cell Line

MAP3K7 Knockout HAP1 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.

Cat. No EDC08167
Species Human
Cell Line HAP1
Gene MAP3K7
Size 1×10⁶cells

Product Details

Cat.No. EDC08167 Product Name MAP3K7 Knockout HAP1 Cell Line
Species Human Cell Line HAP1
Cellosaurus ID CVCL_0F62 NCBI Gene ID
Cell Line Synonyms Highly Aggressively Proliferating Immortalized Gene
Gene Synonyms CSCF|FMD2|MEKK7|TAK1|TGF1a Summary
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Digestion Time 2 min Morphology Adherent
Passage Ratio 1:8~1:10 Complete Culture Medium IMDM+10%FBS
Freezing Medium 90%FBS+10%DMSO
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.

FAQ

The choice depends on whether you are studying MAP3K7 (TAK1)'s role as a central MAP3K in NF-κB and JNK/p38 activation downstream of TLRs, IL-1R, and TNFR signaling. The Knockout line is the standard tool for asking whether TAK1 is required for these processes — TAK1 is the principal MAP3K downstream of TAB1/TAB2/TAB3 scaffolds, activated by K63-polyubiquitination, and required for IKK-NF-κB activation and stress kinase activation in many inflammatory contexts. Overexpression is useful for studying TAK1 in heterologous expression contexts. For inflammatory signaling research, the EDITGENE MAP3K7 Knockout in HAP1 is highly informative — TAK1 is a master regulator of innate immune signaling and a validated drug target. Rescue with wild-type, kinase-dead (K63A), or TAB-binding-deficient TAK1 enables comprehensive structure-function studies. The knockout is a critical specificity control for TAK1 inhibitors (5Z-7-oxozeaenol, takinib) in inflammation and cancer drug development — TAK1 inhibition causes synthetic lethality in KRAS-mutant cancers and has emerged as a therapeutic target.
Yes. TAK1 rescue experiments are well-established for inflammatory signaling research: • Construct design: use a codon-modified MAP3K7 sequence with a small C-terminal tag (FLAG, HA). TAK1 has N-terminal kinase domain and C-terminal TAB-binding regulatory region — preserve all elements. • Kinase-dead rescue: K63A mutation in the ATP-binding lysine abolishes catalytic activity and is the standard specificity control (note: this is the K63 ATP-binding residue, not K63 of ubiquitin chains). • TAB-binding-deficient rescue: C-terminal TAB-interaction region mutations disrupt scaffolding without affecting kinase activity. • K63-polyubiquitin-binding-deficient rescue: TAB2/TAB3 partnership is required for K63-ubiquitin sensing — rescue interpretation considers TAB protein expression. • Functional readout: rescue should restore IL-1, TNF, or TLR-induced NF-κB and JNK/p38 activation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Contact Us
*
*
*
How did you hear about us: